CARY, N.C.--(BUSINESS WIRE)--The CEO Roundtable on Cancer has accredited Infinity Pharmaceuticals, Inc. in Cambridge, MA with the CEO Cancer Gold StandardTM recognizing the company’s efforts to reduce the risk of cancer for its employees and covered family members.
This nonprofit organization of CEOs, founded by former President George H.W. Bush, created the Gold Standard in collaboration with the National Cancer Institute (NCI), many of its designated cancer centers, and other leading health organizations. The Gold Standard requires employers to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to reduce the risk of cancer in the workplace.
“Adopting the Gold Standard is a tribute to the extraordinary leadership of Infinity Pharmaceuticals and to their determination to provide inspiration to organizations large and small that are committed to playing an active role in winning the battle against cancer,” said Christopher A. Viehbacher, chief executive officer of Sanofi and chairman of the CEO Roundtable on Cancer.
To earn Gold Standard accreditation, an employer must establish programs to reduce cancer risk by prohibiting tobacco use and supporting tobacco cessation efforts, further encouraging prevention by promoting physical activity, healthy nutrition and weight management; detecting cancer at its earliest stages; and providing access to quality care, including participation in clinical trials. Today, over four and a half million employees and family members are benefiting from the vision and leadership of 170 employers who have chosen to become Gold Standard accredited.
“We are honored to receive the CEO Cancer Gold Standard accreditation, which highlights our company-wide commitment to incorporating wellness into our culture at Infinity,” stated Adelene Q. Perkins, chair and chief executive officer of Infinity. “We have a comprehensive wellness program for our Citizen Owners – or employees – at Infinity because we believe fostering a culture of healthy living and wellness enables us to do our best work as we strive to discover, develop and deliver innovative, important new medicines to people that make a material difference in their health, well-being and lives.”
In addition to NCI and the Centers for Disease Control and Prevention, 16 NCI-designated cancer centers and more than 60 other hospitals have earned Gold Standard accreditation. CEOs from many industries are keenly aware of the life-improving impact they can have on health and controlling healthcare costs when they address cancer and other chronic diseases. Gold Standard employers include: Avis Budget Group, Harvard School of Public Health, Lowe’s, Aetna, State Farm, Hogan Lovells, Dell, Johnson & Johnson, Novartis, SAS and many Blue Cross affiliates.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. For more information on Infinity, please refer to the company’s website at www.infi.com.
About The CEO Roundtable on Cancer
The CEO Roundtable on Cancer was founded in 2001, when former President George H.W. Bush challenged a group of executives to "do something bold and venturesome about cancer within your own corporate families." The CEOs responded by creating and encouraging the widespread adoption of the CEO Cancer Gold Standard™ which calls for organizations to evaluate their health benefits and workplace culture and take extensive, concrete actions in five key areas of health and wellness to address cancer in the workplace. For more information on the CEO Cancer Gold Standard and the free web-based accreditation process, please visit www.CancerGoldStandard.org.